fda approved glp 1 for weight loss Approves Oral Semaglutide as First GLP-1 Pill With FDA approval of Wegovy
Description
The FDA also recommends exercising caution related to compounded versions, particularly those obtained online, as their contents are not regulated or verified

Expected side effects at prescribed doses include nausea, vomiting, diarrhea and abdominal pain

After reconstitution, refrigerate at 2-8 degrees Celsius and use within 4-6 weeks

(2024, June 28)
The goal is different entirely

Some plans exclude weight loss drugs entirely